Limptar

for treatment of nocturnal leg cramps

Also Known As:

Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-, sulfate (2:1) (salt), mixt. with 3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione compd. with 1,2-ethanediamine (1:1)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Sleep-Wake Transition Disorders (Sleep Talking) 03/28/1980 - "In 22 patients with nocturnal leg cramps a four week double blind study with a combination of quinine sulphate and aminophylline (Limptar) was started. " 02/01/1991 - "164 patients (m = 45, w = 119; age 55.7 +/- 14.7 years) took part in a multicentric controlled parallel-double blind study in which efficacy and tolerability of the combination quinine sulfate (CAS 6119-70-6) plus theophylline ethylene diamine (CTED, CAS 317-34-0) (Limptar) in the treatment of the recurrent nocturnal leg cramps were investigated. "
2.	Muscle Cramp (Cramp) 03/28/1980 - "Unequivocally, Limptar significantly reduced the number and the intensity of nocturnal or recumbency leg cramps. "

Related Drugs and Biologics

1.	Quinine (Quinson)
2.	Theophylline (Theon)
3.	Diamines
4.	Aminophylline (Carine)
5.	ethylene